CAMELI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 89
EU - Europa 84
AS - Asia 16
Totale 189
Nazione #
US - Stati Uniti d'America 89
IT - Italia 25
PL - Polonia 22
IE - Irlanda 15
SE - Svezia 8
HK - Hong Kong 5
DE - Germania 4
RU - Federazione Russa 4
VN - Vietnam 4
BE - Belgio 3
SG - Singapore 3
CN - Cina 2
CH - Svizzera 1
FI - Finlandia 1
JO - Giordania 1
KR - Corea 1
NL - Olanda 1
Totale 189
Città #
Warsaw 22
Dublin 15
Chandler 14
Ann Arbor 10
Fairfield 8
Ashburn 6
Dong Ket 4
Florence 4
Lawrence 4
Moscow 4
Seattle 4
Woodbridge 4
Altamura 3
Boston 3
Brussels 3
Houston 3
Princeton 3
Boardman 2
Buffalo 2
Cambridge 2
Hong Kong 2
Kent 2
Milan 2
New York 2
Pisa 2
San Diego 2
Sesto Fiorentino 2
Singapore 2
Turin 2
Wilmington 2
Amsterdam 1
Duisburg 1
Falls Church 1
Lappeenranta 1
Medford 1
Naples 1
Palermo 1
Seoul 1
Villarsiviriaux 1
Totale 149
Nome #
OP0148 MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A RETROSPECTIVE REAL-WORLD EUROPEAN STUDY ON 142 PATIENTS 72
Systematic Review and Metanalysis of Oncomarkers in IPF Patients and Serial Changes of Oncomarkers in a Prospective Italian Real-Life Case Series 51
Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do? 51
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 15
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study 5
Switching from one biologic to benralizumab in patients with severe eosinophilic asthma: An ANANKE study post hoc analysis 2
Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study 1
Sustained Effectiveness of Benralizumab in Naïve and Biologics-Experienced Severe Eosinophilic Asthma Patients: Results from the ANANKE Study 1
Totale 198
Categoria #
all - tutte 1.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.126


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 0 0 0 0 4 0
2020/202138 1 0 1 1 2 2 2 8 6 9 2 4
2021/202238 0 0 10 1 3 5 0 1 8 1 3 6
2022/202365 8 9 7 3 2 12 12 6 3 0 2 1
2023/202450 3 4 3 1 1 5 1 3 1 10 9 9
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 198